Elizabeth Glaser was one of the first public figures to advocate for research focused on the prevention and treatment of HIV and AIDS in children. Since Elizabeth’s initial efforts, EGPAF has continued to bring together leading international scientists to conduct basic, clinical, and operations research as part of our global efforts to eliminate pediatric AIDS.

Over the last quarter century, the international research community has achieved great progress in deepening its scientific understanding of pediatric HIV and AIDS, leading to the development of a variety of tools to address the epidemic among children. Most notably, research breakthroughs have led to significant reductions in rates of mother-to-child transmission of HIV in even the most resource-limited settings, while improvements in pediatric HIV treatments have ensured that children living with HIV can now enjoy long and healthy lives.


Research Focus

There are numerous pressing research issues that may hold the keys to uncovering new means of preventing mother-to-child transmission of HIV -- and to eliminating pediatric AIDS once and for all.

Learn More

Current Research Activities

Today, EGPAF plays a critical role in both defining the pediatric AIDS research agenda and supporting and conducting research to improve the lives of women, children, and families affected by HIV.

Learn More

Priorities for Future Research

EGPAF is constantly exploring new avenues for research into pediatric HIV and AIDS, and seeks to engage the world's top researchers and practitioners in the quest to create a generation free of HIV.

Learn More

HIV/AIDS Organizations and Online Resources

Learn more about other organizations doing groundbreaking research in the field of HIV/AIDS.

Learn More

Research Highlights

Read more about recent advances in research, personal stories, and more.

Learn More